Dr. Sunil Sharma’s medical prowess unifies basic scientific discoveries, translational drug development and clinical care to produce advanced treatments for patientsContinue reading
Author Archive: AZBio
NuvOx Announces MHRA Approval to Commence Phase IIb Stroke Trial
Tucson, AZ, February 14, 2025 –(PR.com)– NuvOx Therapeutics, Inc. (“NuvOx”) announced that The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom in collaboration with the Research Ethics Committee has accepted the amended request for a clinical trial authorisation (CTA). This acceptance will enable the company to commence the Phase IIb NOVEL trial (NanO2 in Large VessEL Occlusion Stroke (NOVEL): a multicentre single-blind, randomised, placebo-controlled blinded biomarker end-point clinical trial of perfluorocarbon in acute ischaemic stroke due to large vessel occlusion (LVO).Continue reading
Three U of A Health Sciences researchers earn Career Development Awards
The University of Arizona Health Sciences Career Development Award program is providing funding for three junior faculty members with independent research projects.Continue reading
The Stephenson Global Pancreatic Cancer Research Institute Launches First-of-Its-Kind Global Scientific Awards to Advance Breakthrough Discovery in Pancreatic Cancer
- Stephenson Global Prize opportunity invites top scientific minds for one of the largest privately funded rewards — Call for Nominations open now through March 14.
- Stephenson Global Scholar Grants seek the most innovative solutions to tackle the challenges of pancreatic cancer — Grant Applications open now through March 14.
Dr. Corey Casper Joins Banner Health as CEO of Banner Research
Dr. Corey Casper is Chief Executive Officer of Banner Research, which transforms discoveries into new diagnostic, treatment and prevention methods for diseases such as Alzheimer’s, Parkinson’s, cardiovascular disease and cancer.Continue reading
NAU achieves R1 research designation
The Carnegie Foundation announced today that Northern Arizona University received R1 research activity designation, the highest classification for research institutes in the United States.Continue reading
Arizona High School Students Invited to Explore Healthcare Careers
The Midwestern University Health Careers Institute offers a free educational opportunity for high school students. The programs is held in Glendale, AZ. Applications close April 1, 2025.Continue reading
TGen appoints Dr. Aleksandar Sekulic as Physician-in-Chief
The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the appointment of Aleksandar Sekulic, M.D., Ph.D., a distinguished physician-scientist known for his work in skin cancer treatment and clinical research, as Physician-in-Chief. Dr. Sekulic specializes in immunotherapy and targeted therapies for a range of skin cancers, from melanoma to rare types of cutaneous lymphoma and epidermal neoplasms. His patient care approach integrates advanced treatments with a focus on individual needs, ensuring comprehensive, whole-person care.Continue reading
Seed fund to help early-stage university startups enters investment phase
Seed fund to help early-stage university startups enters investment phaseContinue reading
BioLab Holdings, Inc. Receives IRB Approval for Trial on Membrane Wrap™
Study will Evaluate Efficacy of Skin Substitute on Venous Leg UlcersContinue reading